Provenienza dei contatti di primo grado di Olivier Protard
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.
17
| Subsidiary | Investment Managers | 17 |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.
16
| Private Company | Investment Managers | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Olivier Protard tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
SpineVision SA
SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Medtronic CoreValve LLC
Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
VERIMATRIX | Semiconductors | Director/Board Member Director/Board Member | |
Sefas Innovation SA
Sefas Innovation SA Packaged SoftwareTechnology Services Sefas Innovation SA provides desktop publishing software and document management solutions. It develops comprehensive suite of document, post composition and production control tools to design, improve, control and manage the production of personalized documents. The firm open print software suite is used by telecoms, financial services, banking, insurance, utilities, public sector organization for the design, composition and production of business to consumer documents. The company was founded in 1991 and is headquartered in Charenton-Le-Pont, France. | Packaged Software | Director/Board Member Director/Board Member | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Founder Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Graduate Degree | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
Ecole Centrale de Nantes | College/University | Undergraduate Degree | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Investment Managers | Director/Board Member | |
Hotel Bookings International Ltd. | Director/Board Member | ||
MD Start SA
MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PIXIUM VISION | Medical Specialties | Founder Director/Board Member Director/Board Member | |
Jolt Capital SAS
Jolt Capital SAS Investment ManagersFinance Jolt Capital SAS (Jolt Capital) is an independent private equity firm founded in 2011 by Jean Schmitt. The firm is headquartered in Paris, France. | Investment Managers | Founder Private Equity Investor | |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Tissium SA
Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Founder Director/Board Member | |
Hi Inov SAS
Hi Inov SAS Investment ManagersFinance Hi Inov SAS (Hi Inov) is the venture capital arm of Dentressangle Initiatives SAS. The firm was founded by Pierre-Henri Dentressangle and Valérie Gombart in 2012. It is headquartered in Paris, France with an additional office in Bavaria, Germany. | Investment Managers | Chief Executive Officer Private Equity Analyst | |
LYSOGENE | Miscellaneous Commercial Services | Director/Board Member | |
CorWave SA
CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GreenTropism SAS
GreenTropism SAS Packaged SoftwareTechnology Services GreenTropism SAS develops embedded software. It offers library of models and database services. The company was founded by Anthony Boulanger in 2014 and is headquartered in Paris, France. | Packaged Software | Director/Board Member Chairman | |
Women Innovating Together In Healthcare
Women Innovating Together In Healthcare Miscellaneous Commercial ServicesCommercial Services Women Innovating Together In Healthcare operates as an organization of accomplished women. The private company is based in Paris, France. The French company was founded by Rafaèle Elisabeth Tordjman. | Miscellaneous Commercial Services | Founder | |
SafeHeal SAS
SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member | |
Parexi SAS | Chairman | ||
Genode Partners SAS | Chief Executive Officer | ||
May Health SAS
May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Chairman | |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Jeito Capital | Chief Executive Officer | ||
CDR-Life Inc.
CDR-Life Inc. BiotechnologyHealth Technology CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017. | Biotechnology | Director/Board Member | |
Innoskel SASU
Innoskel SASU BiotechnologyHealth Technology Innoskel SASU is a French bioscience platform company that aims to improve the quality of life of patients with severe rare bone disorders. Innoskel is based in Valbonne, France, and was founded by Elvire Gouze, who has been the CEO since incorporation. The company achieves this goal through patient centricity, scientific innovation, and operational excellence. Innoskel is developing transformative therapies for the unmet needs of individuals with rare bone disorders, with a focus on type II collagen disorders. The company's lead asset is INS-101, a gene therapy that has shown strong efficacy in preclinical studies. | Biotechnology | Chairman | |
Moon Surgical SAS
Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit. | Medical Specialties | Director/Board Member Director/Board Member | |
Edamame Technologies SAS | Consultant / Advisor |
Statistiche
Distribuzione geografica
Francia | 36 |
Regno Unito | 7 |
Svizzera | 5 |
Stati Uniti | 3 |
Italia | 3 |
Settori
Health Technology | 27 |
Consumer Services | 6 |
Commercial Services | 6 |
Finance | 5 |
Technology Services | 4 |
Posizioni
Director/Board Member | 232 |
Chairman | 47 |
Corporate Officer/Principal | 42 |
Private Equity Investor | 35 |
Founder | 29 |
Contatti più connessi
Insiders | |
---|---|
Antoine Papiernik | 48 |
Jean Schmitt | 35 |
Bernard Gilly | 32 |
Graziano Seghezzi | 26 |
Denis Lucquin | 26 |
Gérard Hascoët | 25 |
Olivier Sichel | 25 |
Rafaèle Elisabeth Tordjman | 23 |
Dan Newman | 17 |
Sébastien Groyer | 15 |
Valérie Gombart | 15 |
Philippe Cases | 15 |
David A. Hytha | 15 |
Robert Woodman | 14 |
Guy Chatelain | 13 |
- Borsa valori
- Insiders
- Olivier Protard
- Connessioni Società